Although the absolute risk for severe COVID-19 in pregnancy remains low, it is now established that pregnant women are at increased risk of severe COVID-19-associated illness compared with non-pregnant women. Such illness may require hospitalisation, admission to intensive care, mechanical ventilation and even cause death. Thus, the prevention of critical COVID-19 infection is of paramount importance for both the mother and her fetus.
Based on the available evidence, FIGO considers there to be minimal risks – actual or theoretical – that would outweigh the potential benefits of vaccination for pregnant women. We therefore support offering COVID-19 vaccines to pregnant and breastfeeding women. In this webinar, leading speakers will set out FIGO’s position on COVID-19 vaccination and also explore the need for counselling skills for OBGYNs to ensure women can make informed choices. Taking a risk-based approach to the benefits of universal protection, our expert speakers will discuss the safety, efficacy and indications of the various vaccines for pregnant and breastfeeding women.
Dr Faysal El Kak (Lebanon) – Vice President, FIGO
Dr Jeanne Conry (USA) – President Elect, FIGO
Professor Dame Lesley Regan (UK) – Honorary Secretary, FIGO
Dr Carlos Füchtner (Bolivia) – President, FIGO
Dr Denise Jamieson (USA) – COVID-19 vaccine for pregnant and breastfeeding women: Evidence for practice
Dr Frank A. Chervenak (USA) – Recommending COVID-19 Vaccination For Pregnant and Breastfeeding Women is Ethically Obligatory
Dr Anwar Nassar (Lebanon, FIGO Safe Motherhood Committee) – FIGO stand on COVID-19 vaccines
The three short presentations will be followed by a panel discussion and audience Q&A.